曾德惠, 曾志, 向俭, 马文秀, 周永闸, 陈先樵. 氯霉素控释眼丸的研究J. 药学学报, 1988, 23(11): 846-849.
引用本文: 曾德惠, 曾志, 向俭, 马文秀, 周永闸, 陈先樵. 氯霉素控释眼丸的研究J. 药学学报, 1988, 23(11): 846-849.
DH Zeng, Z Zeng, J Xiang, WX Ma, YZ Zhou , XQ Chen, . STUDIES ON THE CHLORAMPHENICOL CONTROLLED RELEASE OCULAR SYSTEMJ. Acta Pharmaceutica Sinica, 1988, 23(11): 846-849.
Citation: DH Zeng, Z Zeng, J Xiang, WX Ma, YZ Zhou , XQ Chen, . STUDIES ON THE CHLORAMPHENICOL CONTROLLED RELEASE OCULAR SYSTEMJ. Acta Pharmaceutica Sinica, 1988, 23(11): 846-849.

氯霉素控释眼丸的研究

STUDIES ON THE CHLORAMPHENICOL CONTROLLED RELEASE OCULAR SYSTEM

  • 摘要: 氯霉素控释眼丸(以下简称眼丸)经体外、眼内试验可持续恒速释药10d,眼内释药量平均为13.35μg/h。眼丸是根据中药“龙虱子”设计,用滴丸工艺制成,于中央钻孔以达到恒速释药。制法简便、成本低、使用方便、安全、疗效可靠。

     

    Abstract: The release of chloramphenicol from the ocular system attained a virtually constant rate of 13.35 μg/h in eyes, and maintained throughout 10 days. It was designed according to the traditional Chinese drug "Long Shi Zi", prepared by the method of pilulae with a perforation in its center. The advantages of chloramphenicol ocular system are: ease of insertion and removal and better resistant to expulsion by movement of the eye because of its small size; simplicity of production and low cost. No irritation or discomfort was observed in clinical trials on 300 patients. The therapeutic values are reliable.

     

/

返回文章
返回